Fig. 1From: Guidelines for molecular testing in non-small cell lung cancer – recommendations from the Brazilian Society of PathologyThe biopsy journey. The pathologist is responsible to design a flow that allows rapid turnaround time at the same time as maximizing tissue availability for molecular studies. Created with BioRender.comBack to article page